Effect of pre-existing Hepatitis C NS3 Q80K variant in Genotype la and NS5A Y93H variant in Genotype 3 for interferon-free treatment combinations with direct antiviral agents (DAAs) : Real-life experience from a multicenter study in Sweden and Norway

Hege Kileng,Midori Kjellin,Assar Bergfors,Ann-Sofi Duberg,Lars Wesslén,Astrid Danielsson,Magnhild Gangsøy Kristiansen,Tore Jarl Gutteberg,Anders Lannergård,Johan Lennerstrand

Effect of pre-existing Hepatitis C NS3 Q80K variant in Genotype la and NS5A Y93H variant in Genotype 3 for interferon-free treatment combinations with direct antiviral agents (DAAs) : Real-life experience from a multicenter study in Sweden and Norway

2016

Hege Kileng
Midori Kjellin
Assar Bergfors
Ann-Sofi Duberg
Lars Wesslén
Astrid Danielsson
Magnhild Gangsøy Kristiansen
Tore Jarl Gutteberg
Anders Lannergård
Johan Lennerstrand

Effect of pre-existing Hepatitis C NS3 Q80K variant in Genotype la and NS5A Y93H variant in Genotype 3 for interferon-free treatment combinations with direct antiviral agents (DAAs) : Real-life experience from a multicenter study in Sweden and Norway

Keywords:

Diabetes mellitus
NS5A
Virology
Biology
Hepatitis C
Interferon
Genotype
NS3
interferon free
multicenter study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations